Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seppo Hiippala

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Annals of Thoracic Surgery|April 29, 2023
Albumin Infusion and Blood Loss After Cardiac SurgeryAkseli Talvasto, Minna Ilmakunnas, Peter Raivio, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|October 31, 2025
Plasma fibrinogen level and severe bleeding in cardiac surgery: an observational post hoc study of the ALBICS trialAkseli Talvasto, Peter Raivio, Minna Ilmakunnas, et al.
Scandinavian Cardiovascular Journal : SCJ|March 31, 2024
In Nordic countries 30-day mortality rate is half that estimated with EuroSCORE II in high-risk adult patients given aprotinin and undergoing mainly complex cardiac proceduresJan van der Linden, Thomas Fux, Timo Kaakinen, et al.
JAMA|July 19, 2022
Effect of 4% Albumin Solution vs Ringer Acetate on Major Adverse Events in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Randomized Clinical TrialEero Pesonen, Hanna Vlasov, Raili Suojaranta, et al.
Trials|March 1, 2020
Effect and safety of 4% albumin in the treatment of cardiac surgery patients: study protocol for the randomized, double-blind, clinical ALBICS (ALBumin In Cardiac Surgery) trialHanna Vlasov, Tatu Juvonen, Seppo Hiippala, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Annals of Thoracic Surgery|April 29, 2023
Albumin Infusion and Blood Loss After Cardiac SurgeryAkseli Talvasto, Minna Ilmakunnas, Peter Raivio, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|October 31, 2025
Plasma fibrinogen level and severe bleeding in cardiac surgery: an observational post hoc study of the ALBICS trialAkseli Talvasto, Peter Raivio, Minna Ilmakunnas, et al.
Scandinavian Cardiovascular Journal : SCJ|March 31, 2024
In Nordic countries 30-day mortality rate is half that estimated with EuroSCORE II in high-risk adult patients given aprotinin and undergoing mainly complex cardiac proceduresJan van der Linden, Thomas Fux, Timo Kaakinen, et al.
JAMA|July 19, 2022
Effect of 4% Albumin Solution vs Ringer Acetate on Major Adverse Events in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Randomized Clinical TrialEero Pesonen, Hanna Vlasov, Raili Suojaranta, et al.
Trials|March 1, 2020
Effect and safety of 4% albumin in the treatment of cardiac surgery patients: study protocol for the randomized, double-blind, clinical ALBICS (ALBumin In Cardiac Surgery) trialHanna Vlasov, Tatu Juvonen, Seppo Hiippala, et al.
Pageof 2